Has Jack Birnbaum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,900 in general payments to Jack Birnbaum, MD across 652 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jack Birnbaum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jack Birnbaum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jack Birnbaum, MD

Endocrinology, Diabetes & Metabolism · Silverdale, WANPI 1801845268

Payments from drug & device makers

$11,900in general payments, 2019–2025

Across 652 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tandem Diabetes Care, Inc.$2K
Boehringer Ingelheim$2K
Novo Nordisk$1K
Amgen$1K
Lilly USA, LLC$923
Sanofi-aventis U.S. LLC$562
plus $4K from 36 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tandem Diabetes Care, Inc.	10	$1,770
Boehringer Ingelheim	111	$1,527
Novo Nordisk	139	$1,437
Amgen(2 entities)	66	$1,209
Lilly USA, LLC	60	$923
Sanofi-aventis U.S. LLC	34	$562
AstraZeneca	29	$510
Novartis	23	$410
Bayer	16	$326
Corcept Therapeutics	12	$259
Dexcom, Inc.	17	$258
Insulet Corporation	10	$242
Xeris Pharmaceuticals, Inc.	11	$230
Lifescan, Inc.	10	$227
Abbott	11	$216
Boston Scientific	9	$191
AbbVie	10	$180
Radius Health, Inc.	9	$159
Amarin Pharma, Inc.	9	$146
Medtronic(2 entities)	5	$131
Recordati_rare_diseases_inc.	5	$125
Esperion Therapeutics, Inc.	6	$112
Mannkind Corporation	4	$87
Johnson & Johnson	5	$85
Merck	5	$82
Pfizer	3	$48
Ultragenyx Pharmaceutical Inc.	2	$47
EUSA Pharma (US) LLC	2	$45
Regeneron Healthcare Solutions, Inc.	2	$44
Kyowa Kirin, Inc.	2	$41
Kowa Pharmaceuticals America, Inc.	3	$39
Antares Pharma, Inc.	2	$37
Zealand Pharma US, Inc.	1	$25
Otsuka America Pharmaceutical, Inc.	1	$25
Azurity Pharmaceuticals, Inc.	1	$24
IBSA Pharma Inc.	1	$23
Arbor Pharmaceuticals, Inc.	1	$23
Lexicon Pharmaceuticals, Inc.	1	$18
Avanir Pharmaceuticals, Inc.	1	$17
Neurocrine Biosciences, Inc.	1	$17
Cequr Corporation	1	$15
BETA Bionics, Inc.	1	$9

How this compares

$11,900 in reported general payments places this provider in the 70th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington →

Medicare billing

Part B allowed, 2024

$6,164

Medicare patients

Services billed

350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Silverdale

Ronald BrazgRenton$17.9M
Frances BroylesSeattle$5.6M
Leslie KlaffRenton$2.8M
Carla GreenbaumSeattle$2.6M
Irl HirschSeattle$2.4M
William HagopianSeattle$2.1M
Carol WyshamSpokane$1.6M
Michael SchwartzSeattle$1.3M
Michael ShannonLacey$698K
Lynn KohlmeierSpokane$518K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →